OPEN APP
Home / News / India /  Pharma sales grew by just 1% in November

NEW DELHI : Growth in pharmaceutical sales slowed down to 1% in November at 12,834 crore, as acute therapies resumed their struggle after a brief sign of recovery, data from market research firm AIOCD-AWACS showed. In October, medicine sales in India stood at 13,542, up nearly 10% year-on-year.

Anti-infectives medicine sales were up 0.2% in November at 1,809 crore, against 6.6% growth recorded in October. Associated therapies like gastrointestinal drugs and pain and analgesics showed a 3.1% growth and 5.2% decline respectively.

Growth in vitamins also slowed down to 6.6% in November from 22.6% in the preceding month.

Respiratory medicines sales slumped at a steeper 6.9% compared to 6.6% in October.

Chronic segments like cardiac care and anti-diabetes drugs which had higher rate of growth during previous months, witnessed a slowdown in November. Cardiac drugs registered a monthly growth of 8.7% compared to 19.5 % in October, while anti-diabetics recorded 1.9% growth against 9.7% in the preceding month.

Barring Cipla and Glenmark Pharmaceuticals, all top 20 drugmakers either recorded single digit growth or a decline. Sales of Micro Lab Mankind Pharma, Pfizer and GlaxoSmithKline Pharmaceuticals were down 0.6-5.4%, the data showed.

Cipla and Glenmark recorded 12.6% and 14.5% growth respectively at 679 crore and 340 crore during the month.

While Glenmark is the market-leader for favipiravir, the best selling covid-19 drug in the country, Cipla has the largest portfolio of covid-19 medicines, which include favipiravir, remdesivir, tocilizumab, among others.

For the country’s largest seller of hydroxychloroquine, Ipca Laboratories, sales growth slowed to 4.9% during the month, reflecting the waning interest in the drug after various clinical trials showed a lack of benefit from the drug against covid-19 after it showed initial promise.

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout